Syndax Pharmaceuticals Inc (NASDAQ:SNDX)

18.97
Delayed Data
As of 3:59pm ET
 +0.30 / +1.61%
Today’s Change
13.02
Today|||52-Week Range
27.85
-14.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues627.0K1.2M2.1M1.5M
 
 
 
 
 
Depreciation And Amortization21.0K89.0K76.0K78.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses21.1M44.9M64.0M77.3M
 
 
 
 
 
Research And Development9.5M31.7M48.2M60.1M
 
 
 
 
 
Total Operating Expenses21.1M45.0M64.1M77.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.5M-43.8M-62.0M-75.9M
 
 
 
 
 
Extraordinary Charge-2.2M-1.7M0.000.00
 
 
 
Interest Expense On Debt1.6M0.000.000.00
 
 
Other Expenses-30.0K41.0K-269.0K-27.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.1M-44.5M-60.8M-74.0M
 
 
 
 
 
Preferred Dividend-79.7M-2.6M0.000.00
 
 
 
Net Income-24.1M-44.5M-60.8M-74.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.0M14.6M21.0M25.4M
 
 
 
 
 
Shares To Calculate EPS Diluted18.0M14.6M21.0M25.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1,519.27-$3.22-$2.90-$2.92
 
 
 
 
 
EPS Diluted-$5.76-$3.22-$2.90-$2.92